Market Indices
Sector Heatmap
ONCY — Oncolytics Biotech, Inc. Common Shares
NasdaqOncolytics Biotech, Inc. Common Shares
- O
- 0.59
- H
- 0.61
- L
- 0.58
- V
- 649.81K
ONCY — Latest News & Headlines
10 StoriesONCY News | ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) - ChartMill
ONCY News | ONCOLYTICS BIOTECH INC (NASDAQ:ONCY) ChartMill
Lab data show an experimental treatment increased immune cells in liver tumors. - Stock Titan
Lab data show an experimental treatment increased immune cells in liver tumors. Stock Titan
ZM Stock Rips To Near 4-Year Highs After Anthropic IPO Filing – Retail Expects A Breakout - Stocktwits
ZM Stock Rips To Near 4-Year Highs After Anthropic IPO Filing – Retail Expects A Breakout Stocktwits
Oncolytics Biotech Announces Progress in REO 033 Trial, Site Activations and FDA-Aligned Pathway for Pelareorep in Metastatic Colorectal Cancer - Quiver Quantitative
Oncolytics Biotech Announces Progress in REO 033 Trial, Site Activations and FDA-Aligned Pathway for Pelareorep in Metastatic Colorectal Cancer Quiver Quantitative
JonesTrading Maintains Oncolytics Biotech(ONCY.US) With Hold Rating - Moomoo
JonesTrading Maintains Oncolytics Biotech(ONCY.US) With Hold Rating Moomoo
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Stocks in play: Oncolytics Biotech Inc The Globe and Mail
Two directors aren't standing for reelection at Oncolytics Biotech (ONCY)'s November 19 meeting. - Stock Titan
Two directors aren't standing for reelection at Oncolytics Biotech (ONCY)'s November 19 meeting. Stock Titan
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc Baystreet.ca
Oncolytics reports pelareorep data in liver cancer study By Investing.com - Investing.com India
Oncolytics reports pelareorep data in liver cancer study By Investing.com Investing.com India
Oncolytics Biotech stock tracks REO 033 progress toward year end - AD HOC NEWS
Oncolytics Biotech stock tracks REO 033 progress toward year end AD HOC NEWS